Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
Update: 2024-03-08
Description
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 8, 2024.
Check out the show notes at MassDevice.com/podcast.
Siemens Healthineers launched a new surgical planning tool. Fast Five hosts Chris Newmarker and Sean Whooley examine the latest application of surgical planning and education using the Apple Vision Plus system.
Nanoflex Robotics announced the first U.S. installations of its surgical robot. The hosts take a look at what this robot does and how Nanoflex hopes to use it to improve the treatment of stroke patients.
Biobot Surgical raised $18 million to support its surgical robot. Newmarker and Whooley break down the unique purpose of this company's surgical robot and discuss the potential uses of proceeds.
Roche Diabetes Care unveiled its new CGM technology with predictive AI algorithms. The Fast Five hosts examine the properties of yet another potential competitor in the CGM market and see if the predictive AI capabilities could set it apart from the rest.
The FTC is reportedly looking into Boston Scientific’s acquisition of Axonics. Following a $3.7 billion acquisition, some questions have arisen around antitrust activity. Newmarker and Whooley look at Bloomberg's report on a potential investigation and break down the potential fallout if this acquisition doesn't go through.
Check out the show notes at MassDevice.com/podcast.
Siemens Healthineers launched a new surgical planning tool. Fast Five hosts Chris Newmarker and Sean Whooley examine the latest application of surgical planning and education using the Apple Vision Plus system.
Nanoflex Robotics announced the first U.S. installations of its surgical robot. The hosts take a look at what this robot does and how Nanoflex hopes to use it to improve the treatment of stroke patients.
Biobot Surgical raised $18 million to support its surgical robot. Newmarker and Whooley break down the unique purpose of this company's surgical robot and discuss the potential uses of proceeds.
Roche Diabetes Care unveiled its new CGM technology with predictive AI algorithms. The Fast Five hosts examine the properties of yet another potential competitor in the CGM market and see if the predictive AI capabilities could set it apart from the rest.
The FTC is reportedly looking into Boston Scientific’s acquisition of Axonics. Following a $3.7 billion acquisition, some questions have arisen around antitrust activity. Newmarker and Whooley look at Bloomberg's report on a potential investigation and break down the potential fallout if this acquisition doesn't go through.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
